GHRL and Huntington disease: Applying this information to the results of our study, high obestatin may be assumed to exhibit antiatherogenic properties in the group of patients with high TNF-α levels and protect them from fatal cardiovascular events, whereas HD patients with high TNF-α but low obestatin levels are lacking such a protection and consequently have worse clinical outcomes.